Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

DuPont investors to vote on Trian demands on May 13

Published 03/23/2015, 11:39 AM
Updated 03/23/2015, 11:39 AM
© Reuters. The DuPont chemical plant is seen in LaPorte, Texas

(Reuters) - DuPont, embroiled in a proxy war with activist investor Trian Fund Management LP for board seats, said it would hold its annual shareholder meeting on May 13.

Trian is seeking four seats on DuPont's board, including one for its Chief Executive Nelson Peltz, to help it force the company to split into two.

DuPont earlier this month rejected the hedge fund's proposal to add two nominees each to its board and the board of a unit it plans to spin off.

The chemical conglomerate, in an attempt to end the proxy war, has said it is prepared to accept one of the fund's nominees, but has refused to add Peltz to its board.

"One of the key reasons Peltz wants to get on (the board) is that he doesn't think anyone would push for a break up (of DuPont) like he would," a person familiar with the matter told Reuters on Monday.

DuPont had said is would spin off its performance chemicals business, but Peltz wants the company to also separate its volatile but cash flow-strong materials businesses from its nutrition and health, agriculture, and industrial biosciences divisions.

DuPont has rejected the proposal, stressing that keeping its businesses together would allow the company to benefit from its science platform, global scale, market access and brand.

Peltz's Trian seemingly softened its stance on the break up in February, saying the fund was "open-minded" about keeping DuPont together.

However, Peltz said in interview to CNBC earlier this month that breaking up the company would be "the most efficient way" to get rid of $2 billion to $4 billion in costs.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Trian's proposal grossly underestimates the significant upfront separation costs and dis-synergies associated with a breakup, both on a one-time and an ongoing basis," DuPont Chief Executive Ellen Kullman said in a letter to shareholders on Monday.

A Trian spokeswoman declined to comment.

DuPont shares were nearly unchanged at $74.34 in morning trade on the New York Stock Exchange. The company's shares have risen 13 percent since Trian went public with its break-up proposal in September.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.